Silk Road Medical Inc

Silk Road Medical Inc (SILK) priced its initial public offering on Apr 4, 2019 at $20.00 per share, within its $19.00–$20.00 range, raising $120M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $604.6M. J.P. Morgan was lead-left underwriter, joined by BMO Capital Markets and Stifel. Wilson Sonsini advised the company and Latham & Watkins advised the underwriters.

Silk Road Medical Inc is a medical device company focused on reducing stroke risk by treating carotid artery disease. It developed transcarotid artery revascularization (TCAR), which uses minimally invasive direct carotid access in the neck and blood flow reversal during the procedure to protect the brain.

Status

IPO

Ticker

SILK

Exchange

Nasdaq Global Market

Priced

Apr 4, 2019

IPO price

$20.00

Price range

$19.00–$20.00

Raised

$120M

Market cap at IPO price

$604.6M

First filed

Mar 4, 2019

Underwriters

J.P. Morgan, BMO Capital Markets and Stifel

Company counsel

Wilson Sonsini

Underwriters' counsel

Latham & Watkins

Sector

Healthcare

Country / state

CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.